Cargando…
Current status of usage of ivermectin in the management of COVID
The antibacterial, antiviral, and anticancer properties of ivermectin make it a wonder drug with a wide range of possible applications. It works against a variety of microorganisms, including viruses. Ivermectin has a wide range of antiviral effects, according to in vivo research in animal models. B...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926582/ https://www.ncbi.nlm.nih.gov/pubmed/36798565 http://dx.doi.org/10.4103/japtr.japtr_344_22 |
_version_ | 1784888307106185216 |
---|---|
author | Ilangovan, Swetha Ganapathy, Dhanraj Ahmed, Nabeel Pandurangan, Kiran Kumar Maiti, Subhabrata |
author_facet | Ilangovan, Swetha Ganapathy, Dhanraj Ahmed, Nabeel Pandurangan, Kiran Kumar Maiti, Subhabrata |
author_sort | Ilangovan, Swetha |
collection | PubMed |
description | The antibacterial, antiviral, and anticancer properties of ivermectin make it a wonder drug with a wide range of possible applications. It works against a variety of microorganisms, including viruses. Ivermectin has a wide range of antiviral effects, according to in vivo research in animal models. Because ivermectin is involved in a range of biological processes, it could be a promising therapeutic candidate for viruses such as COVID-19 and other positive-sense single-stranded RNA viruses. The study aims to analyze the awareness about the current status of usage of ivermectin in management of COVID among students studying in a private dental college. A study based on questionnaire was organized among students studying in a private dental college in Tamil Nadu. The subjects were asked a series of structural questions based on the usage of ivermectin in management of COVID. The questionnaire was prepared with 10 questions. 150 individuals completed the questionnaire; all of their answers were tallied in excel and imported into SPSS. For statistical analysis, the Chi-square test was performed. Excel was used to tabulate and enter the data, and the SPSS package software was used to analyze it. The study's threshold for statistical significance was set at P < 0.05. From this study, we found that the students had limited knowledge about the usage of ivermectin for management of COVID. More studies should be conducted to widen the knowledge among the students about the current affairs of the world. |
format | Online Article Text |
id | pubmed-9926582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-99265822023-02-15 Current status of usage of ivermectin in the management of COVID Ilangovan, Swetha Ganapathy, Dhanraj Ahmed, Nabeel Pandurangan, Kiran Kumar Maiti, Subhabrata J Adv Pharm Technol Res Original Article The antibacterial, antiviral, and anticancer properties of ivermectin make it a wonder drug with a wide range of possible applications. It works against a variety of microorganisms, including viruses. Ivermectin has a wide range of antiviral effects, according to in vivo research in animal models. Because ivermectin is involved in a range of biological processes, it could be a promising therapeutic candidate for viruses such as COVID-19 and other positive-sense single-stranded RNA viruses. The study aims to analyze the awareness about the current status of usage of ivermectin in management of COVID among students studying in a private dental college. A study based on questionnaire was organized among students studying in a private dental college in Tamil Nadu. The subjects were asked a series of structural questions based on the usage of ivermectin in management of COVID. The questionnaire was prepared with 10 questions. 150 individuals completed the questionnaire; all of their answers were tallied in excel and imported into SPSS. For statistical analysis, the Chi-square test was performed. Excel was used to tabulate and enter the data, and the SPSS package software was used to analyze it. The study's threshold for statistical significance was set at P < 0.05. From this study, we found that the students had limited knowledge about the usage of ivermectin for management of COVID. More studies should be conducted to widen the knowledge among the students about the current affairs of the world. Wolters Kluwer - Medknow 2022-12 2022-12-30 /pmc/articles/PMC9926582/ /pubmed/36798565 http://dx.doi.org/10.4103/japtr.japtr_344_22 Text en Copyright: © 2022 Journal of Advanced Pharmaceutical Technology & Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Ilangovan, Swetha Ganapathy, Dhanraj Ahmed, Nabeel Pandurangan, Kiran Kumar Maiti, Subhabrata Current status of usage of ivermectin in the management of COVID |
title | Current status of usage of ivermectin in the management of COVID |
title_full | Current status of usage of ivermectin in the management of COVID |
title_fullStr | Current status of usage of ivermectin in the management of COVID |
title_full_unstemmed | Current status of usage of ivermectin in the management of COVID |
title_short | Current status of usage of ivermectin in the management of COVID |
title_sort | current status of usage of ivermectin in the management of covid |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926582/ https://www.ncbi.nlm.nih.gov/pubmed/36798565 http://dx.doi.org/10.4103/japtr.japtr_344_22 |
work_keys_str_mv | AT ilangovanswetha currentstatusofusageofivermectininthemanagementofcovid AT ganapathydhanraj currentstatusofusageofivermectininthemanagementofcovid AT ahmednabeel currentstatusofusageofivermectininthemanagementofcovid AT pandurangankirankumar currentstatusofusageofivermectininthemanagementofcovid AT maitisubhabrata currentstatusofusageofivermectininthemanagementofcovid |